Qiagen N.V.
QGEN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $10 | $9 | $10 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $2 | $1 | $1 | $1 |
| Enterprise Value | $10 | $11 | $10 | $11 |
| Revenue | $1 | $1 | $0 | $1 |
| % Growth | -0.2% | 10.4% | -7.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.2% | 62.7% | 63.8% | 63.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 52.1% | 34.5% | 35.3% | 35% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 24.4% | 18% | 18.8% | 16.9% |
| EPS Diluted | 0.6 | 0.44 | 0.41 | 0.41 |
| % Growth | 36.4% | 7.3% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |